NOTRELOAD AI
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
Sign in Subscribe

Ligand Buys Xoma for $740M, Doubling Its Drug Royalty Portfolio

Ligand buys Xoma for $740M cash, boosting its drug royalty portfolio to 200+ medicines and spreading investment risk.

Ligand Buys Xoma for $740M, Doubling Its Drug Royalty Portfolio
XOMA Royalty Portfolio
Already have an account? Sign in.
04/27/2026 · 6:50 AM
XOMA
/ Don’t stop at just one post.

Related↓

Wells Fargo Upgrades GLUE, Jefferies Downgrades GBIO
12/16/2025 · 6:42 AM

Wells Fargo Upgrades GLUE, Jefferies Downgrades GBIO

Wells Fargo upgrades Monte Rosa Therapeutics on 2026 catalysts, while Jefferies downgrades Generation Bio due to its pending acquisition by Xoma.

/ Subscriber only
/ Read more

Feed↓

SpaceX Catches Starship for First Time After Returning From Orbit
Featured/ 11/15/2026 · 6:13 AM

SpaceX Catches Starship for First Time After Returning From Orbit

SpaceX’s Starship upper stage returned from a 22-hour orbital mission and was caught by the launch tower for the first time, marking a key reusability milestone.

/ Subscriber only
Amazon revives talks with Rick Perry’s Fermi America on 600 MW Texas power deal
Featured/ 11/13/2026 · 4:06 PM

Amazon revives talks with Rick Perry’s Fermi America on 600 MW Texas power deal

The Financial Times reports Amazon is the hyperscaler behind Fermi America’s new 600 MW power deals following the breakdown of 2025 talks.

/ Subscriber only
Meta Tests Play-Money Prediction Market App Internally as It Eyes the Sector
11/13/2026 · 3:46 PM

Meta Tests Play-Money Prediction Market App Internally as It Eyes the Sector

Meta’s internal prediction market app Takes lets employees bet with credibility points instead of cash. Launch plans remain unclear.

/ Subscriber only
Explore
  • NOTRELOAD AI
  • Invest ↗
  • myNOTRELOAD
  • XY Feed
  • 24-HOUR Pass ↗
  • Push Notifications
More
  • Sign up
  • Sign in
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Terms/Privacy
  • UP↑
Get alerts

Be the first to know when deals break, stocks move, or biotech headlines hit.

Email address Subscribe
DON'T FALL BEHIND. ©2026
For informational purposes only. Not financial advice.
NOTRELOAD AI